Education
About Us
Working with TipRanks
Follow Us
Aarti Drugs Limited (IN:AARTIDRUGS)
:AARTIDRUGS
Total Valuation
Aarti Drugs Limited has a market cap or net worth of ₹40.26B. The enterprise value is ₹19.84B.
Market Cap₹40.26B
Enterprise Value₹19.84B
Share Statistics
Aarti Drugs Limited has 91,270,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding91,270,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aarti Drugs Limited’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 28.14%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)28.14%
Return on Capital Employed (ROCE)0.42
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.93
Inventory Turnover3.26
Valuation Ratios
The current PE Ratio of Aarti Drugs Limited is 18.70. Aarti Drugs Limited’s PEG ratio is 1.85.
PE Ratio18.70
PS Ratio0.00
PB Ratio2.73
Price to Fair Value2.30
Price to FCF21.53
Price to Operating Cash Flow10.35
PEG Ratio1.85
Income Statement
In the last 12 months, Aarti Drugs Limited had revenue of 23.87B and earned 1.68B in profits. Earnings per share was 18.35.
Revenue23.87B
Gross Profit8.45B
Operating Income7.33B
Pretax Income2.12B
Net Income1.68B
EBITDA2.87B
Earnings Per Share (EPS)18.35
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Aarti Drugs Limited pays an annual dividend of ₹1, resulting in a dividend yield of 0.23%
Dividend Per Share₹1
Dividend Yield0.23%
Payout Ratio5.43%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.01
52-Week Price Change-14.20%
50-Day Moving Average423.93
200-Day Moving Average438.95
Relative Strength Index (RSI)41.32
Average Volume (3m)22.63K
Important Dates
Aarti Drugs Limited upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateMay 6, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend DateFeb 04, 2025
Financial Position
Aarti Drugs Limited as a current ratio of 1.60, with Debt / Equity ratio of 93.33%
Current Ratio1.60
Quick Ratio1.03
Debt to Market Cap0.19
Net Debt to EBITDA2.12
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Aarti Drugs Limited has paid 436.80M in taxes.
Income Tax436.80M
Effective Tax Rate0.21
Enterprise Valuation
Aarti Drugs Limited EV to EBITDA ratio is 13.07, with an EV/FCF ratio of 55.65.
EV to Sales1.57
EV to EBITDA13.07
EV to Free Cash Flow55.65
EV to Operating Cash Flow15.34
Balance Sheet
Aarti Drugs Limited has ₹226.10M in cash and marketable securities with ₹6.15B in debt, giving a net cash position of ₹5.92B billion.
Cash & Marketable Securities₹226.10M
Total Debt₹6.15B
Net Cash₹5.92B
Net Cash Per Share₹64.91
Tangible Book Value Per Share₹148.65
Margins
Gross margin is 20.10%, with operating margin of 30.70%, and net profit margin of 7.04%.
Gross Margin20.10%
Operating Margin30.70%
Pretax Margin8.87%
Net Profit Margin7.04%
EBITDA Margin12.03%
EBIT Margin9.69%
Analyst Forecast
The average price target for Aarti Drugs Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―